Novavax Medical Information

THIS PAGE IS INTENDED FOR RESIDENTS OF Poland ONLY.

If you are a Healthcare Professional in Poland, please switch to the Healthcare Professional Medical Information page.

Information on the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)

If your enquiry is regarding the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resource below.

Request Medical Information

Novavax is unable to provide medical advice regarding your health condition. Please consult your doctor, nurse or other healthcare provider, who is in the best position to advise you about the suitability of a particular treatment as they have access to the details of your medical history, as well as information on all medicinal products.

To ask Novavax Medical Information a question about a Novavax product please call
+48 22 104 74 91 between 09:00–17:00.

Report an Adverse Event (AE)

If you are concerned about any potential side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the Package Leaflet.

Alternatively, adverse events of serious concern in association with a Novavax product can be reported to the Office for Medicinal Products, Medical Devices and Biocides at http://www.urpl.gov.pl or to Novavax Pharmacovigilance at +48 22 104 74 91 or via the Novavax Adverse Event Reporting Form.

Report a Product Quality Complaint

If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +48 22 104 74 91 between 09:00–17:00.